AcrySof ReSTOR
 

About AcrSof®  ReSTOR® IOL

AcrySof® ReSTOR® IOL the first and only apodized diffractive IOL for cataract patients with and without presbyopia, uses a unique, patented apodized diffractive technology to provide patients with a full range of quality vision (near, intermediate and distance), and greatly reduce their reliance on glasses.  This optic design result in an increased range of quality vision that delivers a high level of spectacle freedom.  Apodization improves image quality by optimizing light energy delivered to the retina by distributing the appropriate amounts of light to near and distant focal points, regardless of lighting situation.  This new IOL is particularly well suited for patients who wish to reduce their dependency on reading glasses and bifocals once their cataract lens is removed.  The AcrySof ®  ReSTOR® IOL is based on the AcrySof ® design and material platform.  AcrySof ® lenses are the fastest growing and most frequently implanted lenses in the world, with more than 22 million implants since their introduction in the early 1990s.  There are approximately three million cataract surgeries performed annually in the United States.  

About Alcon 

Alcon, Inc. is the world’s leading eye care company with sales exceeding $3.9 billion in 2004.  Global sales of its IOLs, primarily the AcrySof® family of lenses, totaled more than $580 million in 2004.  Alcon, which has been dedicated to the ophthalmic industry for over 50 years, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. For more information on Alcon, Inc., Visit the company’s Web site at www.alconinc.com.